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Verapamil Prevents the Development of Alcoholic Dysfunction in
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Ethanol causes depression of cardiac function. A new
model in hamsters was developed for studying ethanol-
induced myocardial dysfunction and the effects of ve-
rapamil in preventing the functional and metabolic de-
rangements caused by ethanol ingestion were evaluated.
Ethanol was added to the drinking water of hamsters in
increasing amounts, reaching 5C% from 5 weeks on. A
control group received plain water only. A third group
had verapamil (1.75 mg/cc) added to the ethanol-water
mixture to evaluate its potential protective effect. After
5, 7 and 12 weeks, the animals were killed and the hearts
perfused using a Langendorfi' heart preparation. Pres-
sures were recorded and metabolic analysis was per-
formed by the freeze-clamp technique.
Ethanol causes both acute and chronic depression of cardiac
function (1-5). The reasons for this loss of contractility are
not clear, although impaired handling of calcium by the
myocardial cells is thought to playa central role (0). These
defects may occur at the cell membrane, sarcoplasmic re-
ticulum, mitochondria or at the level of the contractile ap-
paratus (7,8). Verapamil, a calcium entry blocker, has dem-
onstrated salutary effects on contractility while preser ving
the nucleotide pool in the inherited cardiomyopathy of the
Syrian hamster (9,10). It is unclear whether this verapamil
effect is specific to the hereditary cardiomyopathic model
or could be demonstrated in a cardiomyopathy of another
origin. Accordingly, we oeveloped and characterized a new
model of cardiac depression caused by ethanol ingestion in
the hamster. The purpose of this study was to assess the
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Compared with control hearts, the hearts from ham-
sters ingesting ethanol showed significant depression of
developed pressure and maximal rate of rise in pressure.
There was also significant depression of high energy
phosphates and adenosine. The animals drinking the
ethanol-verapamil mixture had preservation of left ven-
tricular performance and high energy phosphates, with
measurements indistinguishable from those of the con-
trol group. In summary, verapamil prevented the de-
velopment of myocardial depression and preserved nor-
mal energy metabolism in hearts of hamsters drinking
50% ethanol.
(J Am Coli CardioI1987;9:1326-31)
functional and metabolic effects of verapamil on this new
model.
Specifically, the goals of this study were to develop a
new model of ethanolic cardiac dysfunction in the Golden
hamster; evaluate the mechanical, biochemical and histo-
logic correlates of this model over time; and assess the
effects of verapamil on preventing the functional and met-
abolic derangements caused by ethanol ingestion.
Methods
Study groups. Forty-five 2 month old 100 g Golden
hamsters were entered into the study and were separated
into nine groups of five hamsters each. There were three
control groups. three groups receiving ethanol and three
receiving ethanol mixed with verapamil. The ethanol was
delivered in drinking water according to the following pro-
tocol: week I, 10% ethanol; week 2,20% ethanol; week 3,
30% ethanol; week 4, 40% ethanol; week 5 to termination
of study, 50% ethanol. Ethanol plus verapamil (1.75 mg/cc)
was administered to three groups in honey-flavored drinking
water to counter the bitter taste of verapamil, using an iden-
tical ethanol regimen as in the ethanol groups. Honey was
not added to the drinking water of the control or ethanol
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groups . The average fluid intake per animal was 13 cc/day
in the control groups and 8 cc/day in the other groups. All
animals were fed standard chow. Three groups were sac-
rificed and studied at 5 weeks and three parallel groups were
studied at 7 and 12 weeks, respectively .
Isolated perfused heart studies. The hamsters were
anesthetized with ether and the heart was removed . The
isolated heart preparation was perfused by the Langendorff
method . The heart was perfused in a modified Krebs-Hen-
seleit solution containing 117 mM sodium chloride , 4.3 mM
potassium chloride, 3.5 mM calcium chloride, 0.1 mM po-
tassium dihydrogen phosphate (KHzP04), 25 mM sodium
bicarbonate, 0.6 mM sodium ethylenediarninetetraacetic acid,
and 15 mM glucose. The perfusion pressure was 100 mm
Hg. Pacing wires leading to a Grass stimulator were inserted
into the base of the right ventricle and the heart was paced
at 250 beats/min. A cannula exiting from the apex of the
left ventricle was connected to a pressure transducer for left
ventricular pressure measurements. The heart was perfused
for 20 minutes before freeze-clamping, during which time
physiologic measurements were made . In earlier studies , it
was shown that the heart reached a stable energy level with
this perfusion time (11) .
Termination of metabolic processes at a predetermined
phase ofthe cardiaccycle was accomplished using the stim-
ulator-triggered freeze-clamp technique . Anvils , cooled by
liquid nitrogen , were driven closed at 80 psi allowing the
temperature in the center of the heart to drop to - 80°C in
5 ms (12), instantaneously terminating metabolic processes .
All processes described in this study were terminated during
diastole. When the anvils were released , the frozen flakes
of heart tissue dropped into liquid nitrogen. These studies
were performed in accordance with the animal welfare reg-
ulations at this institution and with the guiding principles
of the American Physiological Society.
Biochemical analysis. Extracts of heart tissue were pre-
pared according to previously described methods (13-16).
The frozen tissue was pulverized under liquid nitrogen ; a
100 mg sample was removed, weighed , dried (l100C) and
weighed again to assess wet to dry weight. Acid (- 200°C,
3 ml 10% perchloric acid) was pulverized separately and
added to the pulverized tissue. Pulverization under liquid
nitrogen continued. The frozen mixture was transferred to
a Sorvall tube and weighed and then transferred to a mortar.
The weight of the cold tube and acid was used as a factor
in calculating the final tissue weight (wet). The frozen mix-
ture was brought to O°C while pulverizing. After centrifu-
gation of the mixture (20,000 g for 5 minutes), the extract
was weighed , neutralized with 5 N potassium hydroxide and
weighed again for determining volume . The mixture was
centrifuged to remove potassium chlorate, and the super-
natant was stored at - 80°C.
Analysisofnucleotide has beendescribedin detailearlier
(11). For separation of adenosine triphosphate (ATP) and
adenosine diphosphate (ADP), a Beckman high performance
liquid chromatograph with a C-18 reverse phase column
was used. For the mobile phase 19% acetonitrile in 0.03 M
KHzP04with 0.01 M tetrabutyammonium (TBA) phosphate
(pH 2.65) was used. Elution was 1 mllmin and detection
by a Beckman ultraviolet spectrophotometer at 254 nm.
Adenosine monophosphate (AMP) was analyzed on the same
column using the same conditions except elution was with
5% acetonitrile in 0.02 M TBA and 0.02 M ~H~P04 ' Aden-
osine was analyzed by injecting 10 p.l of extract onto the
same column using a 10 minute gradient of 0 to 20% meth-
anol in water, followed by a i0 minute elution time at 20%
methanol. Detection and volume elution were the same.
Phosphocreatine and creatine were analyzed on the same
column except elution was I.S mllmin with 0.2% KHzP04
and 0.1% TBA, pH 2.65. Detection was at 210 nm. Cyclic
adenosine monophosphate was determined by radioimmu-
nassay .
Histologic analysis. Histologic studies were performed
on three randomly selected hearts from each group at 7 and
12 weeks to ascertain whether any structural changes oc-
curred in the hamster myocardium that could be correlated
with the associated mechanical and biochemical character-
istics. The heart was cut into 2 mm slices and fixed at 4°C
in 4% parafonnaldehyde in 0.1 M phosphate buffer (pH
7.4). Tissue processing and plastic embedding were per-
formed according to the method of Beckstead (17). Sections
(2 to 3 p.m) were stained with a modified Maximow's stain
(hematoxylin-eosin-azure) before examination with a light
microscope. For electron microscopy , tissue was fixed over-
night in a solution of 2.5% glutaraldehyde, 0.08 sodium
cacodylate, 5 roM calcium chloride and 1% sucrose (pH
7.4) and postfixed for 2 hours in 1.5% osmium tetroxide in
30 mM barbital acetate buffer (pH 7.4). After dehydration
in ethanol and embedding in Epon 812, semithin sections
were cut and stained with toluidine blue for light micros-
copy . Representative areas from these sections (areas that
appeared to have all of the normal elements of myocardium)
were chosen for thin sectioning and were stained with uranyl
acetate and lead citrate and examined in a lEOL lOGS elec-
tron microscope .
Statistical analysis. Mechanical and biochemical char-
acteristics were evaluated by analysis of variance using a
linear regression model to test for the independent effects
of time and assigned treatment and to assess the possibility
Table l. Effect of Treatment on Body Weight
Weight (g)
Time Ethanol Plus
(weeks) Control Ethanol Yerapamil
5 190 ± 15 205 :t 20 190 ± 24
7 215 ± 7 194 :t 24 190 ± 24
12 185 ± 7 195 :t 25 172 ± 30
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of interactions between assigned treatment and time (for
instance, was there a change in response to the ethanol
regimen over time in the hamsters that received ethanol
alone). Differences were considered significant at proba-
bility (p) < 0.05.
Results
There was no significant difference in body weight among
the control, ethanol plus verapamil and ethanol groups at
any time period (Table I). Hamsters that were either in the
ethanol or the ethanol plus verapamil group were subjec-
tively different from the control animals; they appeared un-
kempt and had an unsteady gait.
Hemodynamic measurements (Fig. 1). Assessmentof
performance characteristics of the hamsters in the ethanol
group at 7 and 12 weeks revealed a significant decrease in
peak left ventricular pressure, maximal rate of rise in pres-
sure and developed pressure when compared with control
hamsters. There was no significant difference between ethanol
and control groups in time to peak pressure, end-diastolic
pressure or half-time to relaxation (RTv,) . A comparison of
the performancecharacteristicsbetween7 and 12weekham-
sters in the ethanol group versus the verapamil plus ethanol
group demonstrated preserved function in the verapamil-
treated hamsters. Furthermore, verapamil-treated animals
had higher peak pressures, rate of rise in pressure and de-
veloped pressures as compared with the ethanol group. No
statistical differences were demonstrated in these variables
between the verapamil plus ethanol and control groups at 7
and 12 weeks.
Biochemical characteristics (Fig. 2). There were sig-
nificant decreases in phosphocreatine/creatine ratio, abso-
lute adenosine triphosphate (ATP), ATP/adenosine diphos-
phate (ADP) ratio and adenosine for ethanol hamsters at 7
and 12 weeks compared with control values. Cyclic AMP
in the ethanol group was 50% over the control value al-
though this was not significant at the p = 0.05 level.
Biochemical characteristics of the verapamilplus ethanol
group were significantly better than those of the ethanol
group at 7 and 12 weeks for ATP/ADP, adenosine and
phosphocreatine/creatine ratio (7 weeks only). Hamsters in
the verapamil plus ethanol group at 7 and 12 weeks had
biochemical characteristics that were not significantly dif-
ferent from control values. The data suggest that the effects
of ethanol and the protective effects of verapamil did not
become apparent until 7 weeks and remained stable at 12
weeks.
Histology. There were no histologic or ultrastructural
abnormalities noted on either light or electron microscopy
in the hearts from either the ethanol or the verapamil plus
ethanol groups.
Discussion
The present study demonstrates depressionof ventricular
function in hearts removed from hamsters drinking ethanol
for 7 to 12 weeks. The 7 week hamster group demonstrated
50
Figure I. Performance characteris-
tics are shown for the three groups
of hamsters (control, ethanol and ve-
rapamil plus ethanol) at 5, 7 and 12
weeks. Dev. := developed; dP/dt =
maximal rate of rise in pressure; EDP
:= end-diastolic pressure; ETOH :=
ethyl alcohol; Peak Pressure := peak
left ventricular pressure; RT'1l = half-
time to relaxation ; Time to Peak :=
time to peak pressure.
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Figure 2. Biochemical characteristics are shown for
the three groupsof hamsters (control, ethanol and ve-
rapamil plus ethanol) at 5, 7 and 12 weeks. ADP =
adenosine diphosphate; AIP = adenosine triphos-
phate; cAMP = cyclic adenosine monophosphate;
EIOH = ethyl alcohol; PCr/Cr = phosphocrea-
tine/creatine ratio.
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the greatest depression in cardiac function and high energy
phosphates. However, even hamsters in the 5 week group
which was almost up to 50% ethanol ingestion, showed
some evidence of cardiac dysfunction and a decrease in high
energy phosphates. There was a moderate improvement in
cardiac function and high energy phosphates by 12 weeks
which may have been due to an adaptive increase in ethanol
metabolism. Myocardial adaptation may have been due to
induction of new isoenzymes or a shift in lipid synthesis, a
compensatory mechanism allowing the animals to better
tolerate the large doses of ethanol (18). Administration of
verapamil concurrently with ethanol resulted in improved
physiologic and biochemical characteristics at all stages.
Pilot studies with verapamil in normal animals have sug-
gested no effect of verapamil on function or metabolism.
Thus, no verapamil control group was studied.
Effects on cardiac performance. Chronic ethanol
ingestion may lead to decreased cardiac performance. This
effect can occur independent of other nutritional factors and
has been observed in vivo and in isolated muscle prepara-
tions (19-21). Alcohol is not metabolized by myocytes and
the circulating concentration of acetaldehyde, the primary
metabolite of ethanol, is negligible. It is unknown (18,22)
whether ethanol ingestion damages the heart through direct
metabolic interactions. The deleterious effects of ethanol on
myocardial performance may be explained on the basis of
a physical interaction of ethanol with cell membranes and
proteins.
Effects on myocardial metabolism. Ethanol affects
myocardial cells at a variety of sites. It is known that ethanol
fluidizes biologic membranes and alters organelles (23). The
fluidized membranes may affect the function of ionophores,
preventing a normal ion flux (24). It has been demonstrated
(7,25,26) that the presence of ethanol interferes with cal-
cium transport by the sarcoplasmic reticulum (27). This
causes increased hydrolysis of ATP, and wasting of cellular
energy reserves. In the presence of ethanol, the sodium-
potassium activated ATPase of the cardiac plasma mem-
brane is inhibited (28-31).
By disturbing the cells' normal homeostatic controls for
calcium, energy production and contraction may both be
directly interfered with by ethanol. Ethanol may therefore
lead to a state of intracellular calcium overload due to leaky
membranes or relative calcium deficiency in organelles such
as the sarcoplasmic reticulum which require ATP to main-
tain normal calcium stores.
Depression of cardiac function by ethanol is not restricted
to membrane effects. It has been shown that the association
of the contractile proteins actin and myosin is inhibited in
vitro in the presence of ethanol (32). Ethanol also blocks
ATP production by directly inhibiting oxidative phospho-
rylation (33,34). Thus, ethanol seems to affect membrane-
bound proteins, calcium transport proteins, mitochondrial
respiration and contractile proteins (35-38).
Mechanisms of verapamil effects. Lindenmayer et al.
(39) demonstrated that in the hereditary cardiomyopathy of
the Syrian hamster, electron transport and calcium uptake
were inhibited. The magnitude of these changes appeared
to be related to the severity of the cardiomyopathy. Jasmin
and Proschek (40) demonstrated that in this model verapamil
was effective at maintaining mitochondrial function and pro-
tecting myocardial cells from necrosis.
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We have previously demonstrated (9,10) that in the my-
opathic Syrian hamster ATP and cyclicAMP levels were
depressed and these changes were associated with a 50%
reduction in cardiac performance. Verapamil was found to
preserve myocardial contractility (41,42) as well as the over-
all nucleotide pool (43) in the hereditary cardiomyopathy
of the Syrian hamster.
Verapamil has been shown to have the following mech-
anisms of action: 1) Verapamil directly blocks the slow
calcium channels (44). 2) Verapamil directly protects mem-
branes and indirectly activates membrane-selective proteins
such as sodium/potassium adenosine triphosphatase (AT-
Pase), calcium ATPase and sodium-calcium exchanges (45).
Thus, the various mechanisms of action reported for ve-
rapamil correlate with the characteristics adversely influ-
enced by ethanol ingestion. An ethanol-induced membrane
disturbance can influence levels of high energy phosphates
and cardiac function. Future studies with other calcium entry
blockers may provide mechanistic clues. For example, in
the inherited cardiomyopathy of the Syrian hamster, vera-
pamil but not diltiazem or nifedipine preserved myocardium
(46). This suggests that the beneficial effect of verapamil
was not due to calcium entry blockade alone, but also to
one of the mechanisms discussed previously.
Conclusion. We have demonstrated that oral ingestion
of ethanol in hamsters produces depression of cardiac per-
formance at 7 and 12 weeks. Biochemical correlates of this
effect support the hypothesis that normal myocardial han-
dling of high energy compounds is altered by ethanol admin-
istration; that ethanol-induced myocardial depression is likely
to be associated with disorders in calcium transport by the
myocardium; and that verapamil prevents depression of me-
chanical function by ethanol and preserves myocardial en-
ergetics.
Verapamil was kindly supplied by Knoll Pharmaceuticals.
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